Japanese pharma major Takeda (TYO: 4502) will present results across a range of cancers, including colorectal, lung, ...

Israeli generics giant Teva Pharmaceutical Industries (NYSE: TEVA) has appointed Matthew Shields as executive vice president of Teva Global Operations (TGO), the company’s manufacturing and supply ...

Sands Capital, an active, long-term investor in leading innovative businesses globally, today announced the close of its third life sciences fund, Sands Capital Life Sciences Pulse Fund III ( Pulse ...

Shares in Merck KGaA (MRK: DE) rose by around 5% in Wednesday’s trading after the Germany-based company presented its first quarter 2024financial results and latest forecast for 2024.

Lexicon released new post-hoc analysis of clinical data showing that Inpefa (sotagliflozin), a dual oral inhibitor of SGLT2 and SGLT1, reduced the risk of heart failure-related events across a ...

Overall spending in the US market for medicines grew by 2.5% and reached $435 billion in 2023.

Japanese drugmaker Eisai (TYO: 4523) has started the rolling submission of a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for Leqembi (lecanemab-irmb) ...

The sBLA is looking to include a four-dose Heplisav-B [hepatitis… • All the news that moves the needle in pharma and biotech. • Exclusive features, podcasts, interviews, data analyses and commentary ...

Norwich Pharmaceuticals has submitted to the US regulator for approval to market a generic version of Xifaxan (rifaximin), a treatment for irritable bowel syndrome. The move could mean imminent ...

Danish CNS specialist Lundbeck (LUND: CO) today reported first-quarter 2024 financials, showing that revenues grew 7% at constant exchange rates (CER) and 5% in kroner terms to 5,288 million kroner ...

Adding to earlier data in the important co-morbidity of cardiovascular disease, the latest results, published in Nature, show that the apparent protective effects of Wegovy (semaglutide) were ...

A biotech company developing first-in-class therapeutics for a wide range of difficult-to-treat diseases, including autoimmune and inflammatory diseases. The US Food and Drug Administration (FDA) on ...